eMedevents
  • 151,456+ Medical Conferences
  • 285 Specialties
  • 11,142 Organizers
  • 155,507 Speakers
  • 159 Countries
  • 4,748 Cities
50,485+
CME Conference Registrations Sold
Home  >  Speakers  >  Emmanuelle Di Tomaso
Emmanuelle Di Tomaso

Emmanuelle Di Tomaso

    PhD
Head | Cambridge, Massachusetts    United States of America
Oncology, Pathology
Oncology, Pathology,...More
Spoken at 3 events

Biography :

Dr. di Tomaso obtained her Ph.D. in Clinical Chemistry at the Institute of Child Health, University College, London, UK. She first focused her career in academia spending 11 years at the Massachusetts General Hospital studying angiogenesis and vascular biology in the context of several cancers. This included the first successful implementation of anti-angiogenic therapy to restore hearing in patients with NF2 acoustic neuroma.

She then spent 7 years at Novartis where she led the precision medicine strategy for multiple clinical programs in late development with a focus on the breast cancer portfolio (including PI3K and CDK4/6 inhibitors). She is currently Head of Translation Medicine at Syros Pharmaceuticals where she established and developed the Translational Medicine function to leverage precision medicine for two drug target candidates discovered by the Syros gene control discovery platform.

**********************
**********
 
For speaker's contact information - Contact us

Specialties

Oncology, Pathology

Interested Topics

Oncology, Pathology, Clinical Chemistry, Vascular Biology, Anti-Angiogenic Therapy, Translation Medicine, Clinical Research, Clinical Biomarkers Strategy, Translational Research

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message